Difficulty: Medium
Average Score: 67%
Practice
A 6-year-old boy cuts his hand on the training wheel of his bicycle. The wound is 1.5 cm in size and the bleeding stops with direct pressure. One of the steps of blood clotting involved platelet aggregation through activation of collagen. Platelet release of granules is mediated by the release of mediators. Which of the following mediators, if activated, will likely cause bleeding to continue?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Serotonin. Serotonin is a vasoconstrictor and plays a role in platelet aggregation. When activated, serotonin promotes vasoconstriction, reducing blood flow to the injured area and enhancing platelet aggregation, thereby aiding in the formation of a stable blood clot.
A) Adenosine diphosphate (ADP) is released by platelets to promote further platelet activation and aggregation, thus helping in the clotting process. It does not cause bleeding to continue.
B) Dopamine is not directly involved in the clotting cascade. It is a neurotransmitter that plays a role in the central nervous system and is not a mediator of platelet activation.
D) Thromboxane A2 is a potent vasoconstrictor and platelet aggregator. It is released by activated platelets to promote further platelet activation and vasoconstriction at the site of injury, helping in clot formation. It does not cause bleeding to continue.
Educational Context:
Understanding the role of different mediators in the clotting process is crucial in pharmacology. Knowing how each mediator functions allows healthcare providers to assess and manage bleeding disorders effectively. In this case, identifying the mediator that could potentially cause bleeding to continue provides insights into the mechanisms of platelet aggregation and clot formation.
A) Adenosine diphosphate (ADP) is released by platelets to promote further platelet activation and aggregation, thus helping in the clotting process. It does not cause bleeding to continue.
B) Dopamine is not directly involved in the clotting cascade. It is a neurotransmitter that plays a role in the central nervous system and is not a mediator of platelet activation.
D) Thromboxane A2 is a potent vasoconstrictor and platelet aggregator. It is released by activated platelets to promote further platelet activation and vasoconstriction at the site of injury, helping in clot formation. It does not cause bleeding to continue.
Educational Context:
Understanding the role of different mediators in the clotting process is crucial in pharmacology. Knowing how each mediator functions allows healthcare providers to assess and manage bleeding disorders effectively. In this case, identifying the mediator that could potentially cause bleeding to continue provides insights into the mechanisms of platelet aggregation and clot formation.